{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=190913", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?uin=190913", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=190913&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&uin=190913", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=190913", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?uin=190913", "items" : [{"_about" : "http://data.parliament.uk/resources/1646793", "AnsweringBody" : [{"_value" : "Department for Environment, Food and Rural Affairs"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1646793/answer", "answerText" : {"_value" : "

We are working on the recycling targets for each packaging material as part of work to finalise our plans for Extended Producer Responsibility. The individual recycling targets for each material will be set to achieve our environmental ambitions taking into account the specific issues and challenges associated with each material.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4522", "label" : {"_value" : "Biography information for Rebecca Pow"} } , "answeringMemberConstituency" : {"_value" : "Taunton Deane"} , "answeringMemberPrinted" : {"_value" : "Rebecca Pow"} , "dateOfAnswer" : {"_value" : "2023-06-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-06-29T11:56:00.027Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "13"} , "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"} , "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"} , "date" : {"_value" : "2023-06-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Packaging: Recycling"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, pursuant to the Answer of 17 May 2023 to Question 184463 on Glass: Deposit Return Schemes, whether she has considered the potential merits of setting a recycling target for (a) glass and (b) polyethylene terephthalate packaging of 90 per cent.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4836", "label" : {"_value" : "Biography information for Ben Everitt"} } , "tablingMemberConstituency" : {"_value" : "Milton Keynes North"} , "tablingMemberPrinted" : [{"_value" : "Ben Everitt"} ], "uin" : "190913"} , {"_about" : "http://data.parliament.uk/resources/1006074", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1006074/answer", "answerText" : {"_value" : "

\u2018Prescribed Medicines: An Evidence Review\u2019 is a public health evidence review of the published evidence and available data. This process is distinct from a public inquiry so the inclusion of individual testimonies would not be appropriate.<\/p>

<\/p>

Public Health England (PHE) is aware of the importance and relevance of the experience of patients in understanding the issues. The review will give significant prominence to the patients\u2019 experiences and examine existing service models through published research and other methods, for example analysis of annual reports of various withdrawal charities.<\/p>

<\/p>

The call for evidence was open to all parties, including pharmaceutical companies. The call for evidence has now closed. The National Guideline Centre (NGC) will provide details on the evidence submitted in their rapid evidence assessment report. The report is due in early 2019.<\/p>

<\/p>

A non-disclosure agreement was not made between PHE and the NGC in relation to the review of literature on prescribed medicines.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-11-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "190914"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-11-20T15:07:46.427Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-11-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Prescription Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 24 October 2018 to Question 180245 on Prescription Drugs, for what reason his Department did not include individual testimony; and what proportion of the published evidence was submitted by pharmaceutical companies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4436", "label" : {"_value" : "Biography information for Cat Smith"} } , "tablingMemberConstituency" : {"_value" : "Lancaster and Fleetwood"} , "tablingMemberPrinted" : [{"_value" : "Cat Smith"} ], "uin" : "190913"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }